BillionToOne, diagnostics firm, files for U.S. IPO after narrowing losses
Diagnostics firm files for U.S. IPO, posts strong revenue growth.
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
News Feed
1 articles
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
positive
8h agoBillionToOne, diagnostics firm, files for U.S. IPO after narrowing losses
Molecular diagnostics company BillionToOne filed for a U.S. IPO, showing H1 2025 revenue of $125.5 million (vs. $69 million prior year) and a narrowed net loss of $4.2 million. The firm develops non-invasive prenatal tests and liquid biopsies. Underwriters include J.P. Morgan, Wells Fargo, and William Blair.
positive
8h agoBillionToOne, diagnostics firm, files for U.S. IPO after narrowing losses
Molecular diagnostics company BillionToOne filed for a U.S. IPO, showing H1 2025 revenue of $125.5 million (vs. $69 million prior year) and a narrowed net loss of $4.2 million. The firm develops non-invasive prenatal tests and liquid biopsies. Underwriters include J.P. Morgan, Wells Fargo, and William Blair.
positive
BillionToOne, diagnostics firm, files for U.S. IPO after narrowing losses
about 8 hours ago
1 min read
47 words
Diagnostics firm files for U.S. IPO, posts strong revenue growth.
Molecular diagnostics company BillionToOne filed for a U.S. IPO, showing H1 2025 revenue of $125.5 million (vs. $69 million prior year) and a narrowed net loss of $4.2 million. The firm develops non-invasive prenatal tests and liquid biopsies. Underwriters include J.P. Morgan, Wells Fargo, and William Blair.
Molecular diagnostics company BillionToOne filed for a U.S. IPO, showing H1 2025 revenue of $125.5 million (vs. $69 million prior year) and a narrowed net loss of $4.2 million. The firm develops non-invasive prenatal tests and liquid biopsies. Underwriters include J.P. Morgan, Wells Fargo, and William Blair.
Companies:
BillionToOne
Tags:
IPO
healthcare
IPO
healthcare
biotech
BillionToOne
diagnostics
Source: